Cancer drug company Epizyme prices IPO, begins trading
May 31, 2013 at 07:55 AM EDT
Epizyme Inc. has priced its initial public offering at $15 a share –— the top of the expected range — and will start trading on the Nasdaq Friday under the ticker symbol, "EPZM...
